2022 American Transplant Congress
Perturbations in Podocyte Transcriptome and Biological Pathways Induced by Injury Caused by FSGS Associated Circulating Factors
1UCSF, San Francisco, CA, 2Rush University, Chicago, IL
*Purpose: Focal segmental glomerulosclerosis (FSGS) remains a disease without specific therapy for primary disease and a high rate of recurrence after renal transplant. Circulating factors…2022 American Transplant Congress
Racial and Immunologic Disparities Impact Access to Repeat Kidney Transplantation Among Patients with Previous Failed Kidney Allograft
1Emory University, Atlanta, GA, 2University of Minnesota, Minneapolis, MN
*Purpose: The number of patients with a failed kidney transplant who are being considered for retransplantation is increasing steadily. However, disparities in access to repeat…2022 American Transplant Congress
Normothermic Machine Perfusion (NMP) Improves Access to Transplantation for Late Liver Re-Transplant Candidates
*Purpose: Late liver re-transplantation (LLrT) is a complex surgical procedure. Candidates for LLrT spend longer on the waitlist than primary transplant candidates due to selectivity…2022 American Transplant Congress
Outcomes Following Liver Re-Transplantation for Delayed Graft Loss in Recipients of Donation After Circulatory Death Allografts in the United States
*Purpose: Donation after circulatory death (DCD) liver transplant (LT) recipients have a higher likelihood of delayed graft loss due to Ischemic cholangiopathy (IC). Limited data…2022 American Transplant Congress
Re-Kidney Transplantation in Patients with Graft Failure: Survival Benefit by Age
1Johns Hopkins University, Baltimore, MD, 2McGill University, Montreal, QC, Canada
*Purpose: As the rates of kidney transplantation (KT) have doubled over the past three decades, so has the proportion of patients who experience graft failure…2022 American Transplant Congress
Effect of Immunosuppression Withdrawal After Graft Failure on Re-Kidney Transplantation Outcomes
1Johns Hopkins University, Baltimore, MD, 2McGill University, Montreal, QC, Canada
*Purpose: The risk and benefit of immunosuppression use after graft failure need to be addressed to improve patient and graft survival after their re-kidney transplantation…2022 American Transplant Congress
Retransplantation in a High-Volume Institution: Historical, Socioeconomic and Survival Trends
The Mount Sinai Hospital, New York, NY
*Purpose: Retransplantation for liver allograft failure is a challenge within the field. The evolution of organ allocation policy from Child to MELD in 2002 and…2022 American Transplant Congress
Liver Transplantation for Primary Sclerosing Cholangitis (psc): Experience from the Last Three Decades
*Purpose: In liver transplantation (LT) for PSC, pre-transplant colectomy may lower the risk of PSC recurrence (rPSC), and well-controlled or lack of IBD may protect…2022 American Transplant Congress
National Landscape of the Utilization of Living Donor Liver Allografts in Redo Liver Transplantation
Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: To examine the use of living donor liver allografts in patient’s requiring redo liver transplantation.*Methods: Using data from SRTR 2009-2020, we evaluated the number…2022 American Transplant Congress
Characteristics and Outcomes of Anhepatic Patients Listed for Liver Retransplantation
1University of Michigan, Ann Arbor, MI, 2University of Pennsylvania, Philadelphia, PA
*Purpose: The frequency and outcomes of anhepatic patients listed for transplantation in the United States has not been previously described. The United Network for Organ…
- 1
- 2
- 3
- …
- 11
- Next Page »